Zevra Therapeutics
Targeting improved therapies for pain, ADHD and other CNS indications.
HQ location
Kissimmee, United States
Founding location
Coralville, United States
Website
Launch date
Employees
Market cap
$492m
Enterprise value
$491m
Share price
$8.81 ZVRA
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| investor investor | €0.0 | round | |
* | N/A | $60.0m | Post IPO Equity |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 116 % | (63 %) | 163 % | (14 %) | 295 % | 73 % | 57 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 28 % | (230 %) | (160 %) | (332 %) | (11 %) | 5 % | 27 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (30 %) | (397 %) | (168 %) | (447 %) | 71 % | 27 % | 48 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 35 % | 188 % | 145 % | 178 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Zevra Therapeutics
Edit
ACQUISITION by Zevra Therapeutics May 2022
ACQUISITION by Zevra Therapeutics Aug 2023